MedTrace Logo

EP Intravenous Anesthesia in Hysteroscopy

NCT05259787 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 366

Last updated 2025-02-28

No results posted yet for this study

Summary

Hysteroscopy is a gold standard method for evaluating the uterine cavity and diseases, which is gradually becoming a day-surgery in China. Propofol is one of the most commonly used intravenous anesthetics in clinic for hysteroscopic procedures, however high dose propofol bring some potential clinical safety hazards.In this study, the feasibility and safety of Etomidate combined with propofol(1:2) as improved scheme for hysteroscopic surgery will be evaluated.

Conditions

  • Anesthesia

Interventions

DRUG

Sedation Etomidate combined with propofol

Drug IV within 10 second during anesthesia induction.

DRUG

Sedation Propofol

Drug IV within 10 second during anesthesia induction.

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Diansan Su, MD,PHD · Renji Hospital, Shanghai Jiaotong University, School of Medcine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-09-28
Primary Completion
2023-12-30
Completion
2023-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05259787 on ClinicalTrials.gov